FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3037928446> ?p ?o ?g. }

• W3037928446 endingPage "475" @default.
• W3037928446 startingPage "466" @default.
• W3037928446 abstract "Previous studies have shown that the development of thrombocytopenia was associated with the elevated plasma concentration of linezolid, but little is known about the relationship between other uncommon adverse drug reactions (ADRs) and plasma concentration. The appropriate dosing adjustment has remained controversial. This prospective observational study was conducted to investigate the association between the plasma concentration of linezolid, ADRs, and clinical outcomes. Adult patients on linezolid treatment undergoing at least one therapeutic drug monitoring (TDM) were enrolled. The association between linezolid concentrations and ADRs was examined by multivariate Cox regression model. Predictors of linezolid concentrations was determined by linear regression model. The cut-off point of linezolid concentration and the effect of dosing adjustments based on TDM was also explored. Of 50 patients enrolled in the study, plasma concentrations were 1.5–3 times higher than what was described in the prescribing information. The median minimum concentration (Cmin) was significantly higher in patients with thrombocytopenia compared to patients without thrombocytopenia (13.0 vs. 7.2 μg/mL, P = 0.0273), and a higher median maximum concentration was also observed in patients with lactic acidosis (33.0 vs. 27.5 μg/mL, P = 0.0420). The Cmin was elevated in patients with advanced age and severely impaired renal function. Dosing adjustment tailored by early TDM with the upper limit of Cmin 9 μg/mL may improve platelet counts. Elevated linezolid concentrations were associated with thrombocytopenia and lactic acidosis. TDM-guided dosing adjustment could be considered as a pragmatic way to mitigate thrombocytopenia." @default.
• W3037928446 created "2020-07-02" @default.
• W3037928446 creator A5000429765 @default.
• W3037928446 creator A5006613668 @default.
• W3037928446 creator A5020276376 @default.
• W3037928446 creator A5037686253 @default.
• W3037928446 creator A5047472547 @default.
• W3037928446 creator A5066348191 @default.
• W3037928446 creator A5078602610 @default.
• W3037928446 creator A5079773948 @default.
• W3037928446 date "2021-01-01" @default.
• W3037928446 modified "2023-09-30" @default.
• W3037928446 title "Impact of high plasma concentrations of linezolid in Taiwanese adult patients— therapeutic drug monitoring in improving adverse drug reactions" @default.
• W3037928446 cites W1987775704 @default.
• W3037928446 cites W2003136021 @default.
• W3037928446 cites W2017719546 @default.
• W3037928446 cites W2029224554 @default.
• W3037928446 cites W2047426311 @default.
• W3037928446 cites W2057605178 @default.
• W3037928446 cites W2060692126 @default.
• W3037928446 cites W2067978628 @default.
• W3037928446 cites W2069428985 @default.
• W3037928446 cites W2077608176 @default.
• W3037928446 cites W2112668624 @default.
• W3037928446 cites W2118683374 @default.
• W3037928446 cites W2118901469 @default.
• W3037928446 cites W2122851467 @default.
• W3037928446 cites W2135796724 @default.
• W3037928446 cites W2138781338 @default.
• W3037928446 cites W2142447693 @default.
• W3037928446 cites W2143949361 @default.
• W3037928446 cites W2145138274 @default.
• W3037928446 cites W2146515240 @default.
• W3037928446 cites W2162081207 @default.
• W3037928446 cites W2164326034 @default.
• W3037928446 cites W2170650380 @default.
• W3037928446 cites W2471293393 @default.
• W3037928446 cites W2586337928 @default.
• W3037928446 cites W2617318576 @default.
• W3037928446 cites W2739399475 @default.
• W3037928446 cites W2772901626 @default.
• W3037928446 doi "https://doi.org/10.1016/j.jfma.2020.06.011" @default.
• W3037928446 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32600864" @default.
• W3037928446 hasPublicationYear "2021" @default.
• W3037928446 type Work @default.
• W3037928446 sameAs 3037928446 @default.
• W3037928446 citedByCount "18" @default.
• W3037928446 countsByYear W30379284462020 @default.
• W3037928446 countsByYear W30379284462021 @default.
• W3037928446 countsByYear W30379284462022 @default.
• W3037928446 countsByYear W30379284462023 @default.
• W3037928446 crossrefType "journal-article" @default.
• W3037928446 hasAuthorship W3037928446A5000429765 @default.
• W3037928446 hasAuthorship W3037928446A5006613668 @default.
• W3037928446 hasAuthorship W3037928446A5020276376 @default.
• W3037928446 hasAuthorship W3037928446A5037686253 @default.
• W3037928446 hasAuthorship W3037928446A5047472547 @default.
• W3037928446 hasAuthorship W3037928446A5066348191 @default.
• W3037928446 hasAuthorship W3037928446A5078602610 @default.
• W3037928446 hasAuthorship W3037928446A5079773948 @default.
• W3037928446 hasBestOaLocation W30379284461 @default.
• W3037928446 hasConcept C112705442 @default.
• W3037928446 hasConcept C126322002 @default.
• W3037928446 hasConcept C197934379 @default.
• W3037928446 hasConcept C22979827 @default.
• W3037928446 hasConcept C2777288759 @default.
• W3037928446 hasConcept C2778335254 @default.
• W3037928446 hasConcept C2778980435 @default.
• W3037928446 hasConcept C2779489039 @default.
• W3037928446 hasConcept C2780035454 @default.
• W3037928446 hasConcept C2780272996 @default.
• W3037928446 hasConcept C2780317664 @default.
• W3037928446 hasConcept C2781414143 @default.
• W3037928446 hasConcept C523546767 @default.
• W3037928446 hasConcept C54355233 @default.
• W3037928446 hasConcept C71924100 @default.
• W3037928446 hasConcept C86803240 @default.
• W3037928446 hasConcept C90924648 @default.
• W3037928446 hasConcept C98274493 @default.
• W3037928446 hasConceptScore W3037928446C112705442 @default.
• W3037928446 hasConceptScore W3037928446C126322002 @default.
• W3037928446 hasConceptScore W3037928446C197934379 @default.
• W3037928446 hasConceptScore W3037928446C22979827 @default.
• W3037928446 hasConceptScore W3037928446C2777288759 @default.
• W3037928446 hasConceptScore W3037928446C2778335254 @default.
• W3037928446 hasConceptScore W3037928446C2778980435 @default.
• W3037928446 hasConceptScore W3037928446C2779489039 @default.
• W3037928446 hasConceptScore W3037928446C2780035454 @default.
• W3037928446 hasConceptScore W3037928446C2780272996 @default.
• W3037928446 hasConceptScore W3037928446C2780317664 @default.
• W3037928446 hasConceptScore W3037928446C2781414143 @default.
• W3037928446 hasConceptScore W3037928446C523546767 @default.
• W3037928446 hasConceptScore W3037928446C54355233 @default.
• W3037928446 hasConceptScore W3037928446C71924100 @default.
• W3037928446 hasConceptScore W3037928446C86803240 @default.
• W3037928446 hasConceptScore W3037928446C90924648 @default.
• W3037928446 hasConceptScore W3037928446C98274493 @default.
• W3037928446 hasFunder F4320323422 @default.

• next